Abstract--Our group is developing a scanner that combines xray, single gamma, and optical imaging on the same rotating gantry. Two functional modalities (SPECT and optical) are included because they have different strengths and weaknesses in terms of spatial and temporal decay lengths in the context of in vivo imaging, and because of the recent advent of multiple reporter gene constructs. The effect of attenuation by biological tissue on the detected intensity of the emitted signal was measured for both gamma and optical imaging. Attenuation by biological tissue was quantified for both the bioluminescent emission of luciferace and for the emission light of the near infrared fluorophore cyanine 5.5, using a fixed excitation light intensity. Experiments were performed to test the feasibility of using either single gamma or x-ray imaging to make depth-dependent corrections to the measured optical signal. Our results suggest that significant improvements in quantitation of optical emission are possible using straightforward correction techniques based on information from other modalities. Development of an integrated scanner in which data from each modality are obtained with the animal in a common configuration will greatly simplify this process.
I. INTRODUCTION
he use of multiple, complementary imaging modalities can greatly enhance the information obtained in an invivo animal study. It is often desirable to obtain such data in quick succession if not simultaneously because of the time evolution of biologic processes in the animal. Additionally, it is also desirable to have the animal in a fixed configuration to permit image co-registration and fusion. We are developing a compact scanner, which will combine x-ray, gamma, and bioluminescence/fluorescence optical imaging on the same rotating gantry. X-ray images will provide anatomic information, whereas gamma and optical images will provide functional information [1, 2] . Two functional modalities are being included because they have very different strengths and weaknesses in the context of in vivo imaging. First, the majority of detected photons in single gamma imaging travel straight paths from the decaying isotope atom to the camera. Therefore the resolution of the source emitters can be as good as the spatial resolution of the camera (~ 1 mm or less). On the other hand, in optical imaging the vast majority of photons have undergone many scattering interactions before reaching the surface of the animal. Thus the spatial distribution of the photons escaping from the surface is not a good approximation of the spatial distribution of the emitters unless the sources are located on the animal's surface. Second, optical probes are typically capable of multiple photon emission from a single molecule, whereas gamma probes are typically labeled with a single radioisotope atom. For example, the bioluminescent reporter firefly luciferace emits light as long as it is in the presence of a catalyst (luciferine) and energy source (ATP). Fluorescent reporters emit light as long as they are exposed to particular excitation radiation. The ability to source many photons means that, despite the enormously higher attenuation of their signal by biological tissue, optical probes can provide sensitivity (i.e. the ability to detect low quantities of the probe) that is superior to that of gamma probes. So while the spatial resolution possible with gamma emission imaging is much higher for subsurface sources, the sensitivity of optical imaging can be several orders of magnitude higher. The recent advent of dual gamma/optical reporter gene constructs such as HSV1-tk/luciferace raises the possibility of combining the strengths of both modalities through the use of simultaneous combined modality imaging. Below, we describe the use of the localization ability of gamma emission imaging as a means of correcting for optical attenuation in fluorescence imaging.
II METHODS AND RESULTS
A. Gamma Emission/Fluorescence Study 1. Attenuation Measurements Annexin V is a protein that is a marker for apoptosis (programmed cell death). It can be labeled with either 99m Tc or the near-IR fluorophore cyanine 5.5 (Cy5.5). In order to better understand the relative net attenuation (including absorption and scattering) of the emitted radiation from 99m Tc (140 keV) and Cy5.5 (peak emission wavelength of 690 nm), a mouse study was performed. First, quantities of 99m Tc and Cy5.5 representative of those that would be found in a typical mouse apoptosis study using Annexin V were determined as follows. The estimated labeling efficiency for Cy5.5-Annexin V is two Cy5.5 molecules for every one Annexin V molecule [4] . The labeling efficiency for 99m Tc has been reported to be ~95% [5] . The specific activity, defined as the activity per unit mass of the labeled protein, is dependent on many factors including the labeling efficiency and the fraction of bound 99m Tc molecules that are undecayed. Values for specific activity resulting from a labeling efficiency of ~95% are reported to range from 10-200 µCi/µg [2] . This corresponds to a range in the fraction Tc-MAA and Cy5.5 were mixed together and injected subcutaneously on the top side of a leg of a mouse. Immediately post injection, both top and bottom views of the mouse were obtained using a dualmodality planar xray and gamma imaging system developed in our lab ( Figure 1 ) and an IVIS Imaging System 100 Series equipped with the XFO-6 Fluorescent option (Xenogen Corp. Alameda, California). The mouse images from the dual modality and optical scanners are shown in Figures 2a and 2b , respectively.
The results shown in Table 1 were obtained from a small ROI drawn in the center of the image of the injection site. The measured optical signal differs by over a factor of 7 depending on the view from which the image is taken with respect to the injection site, while the measured gamma signal is nearly independent of the viewing side.
We next quantified the attenuation of the radiation emitted by 99m Tc and by cyanine 5.5 using a surrogate biological tissue (cooked ham). 100 µCi of 99m Tc and 50 µg of the near-IR fluorophore cyanine 5.5 were placed in a spherical simulated lesion of 10 mm inner diameter. Varying numbers of 1 mm thick slices of cooked ham were placed over the lesion, and the amount of detected radiation was determined by region of interest analysis of the gamma and optical images. Integration times were held constant for both imaging systems at 3 seconds for optical and 60 seconds for gamma. The results are shown in Figure 3 . The optical signal is reduced to 1% of its original value by 10 mm of ham, whereas the gamma signal is only reduced to 88% of its initial level. Based on a straight line fit to the optical Figure 2a . Dual modality x-ray/gamma image (left), and Xenogen IVIS image (right). In these images, the gamma camera and the IVIS scanner both viewed the mouse from the dorsal side. 
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transmission data of Fig. 3 , an approximately exponential attenuation of the optical signal is observed, with an effective linear attenuation coefficient of ~0.5 mm -1 . It is important to note that this attenuation coefficient takes into account both the attenuation of the excitation radiation (615 -660 nm) and of the emitted fluorescence light. The majority of the emission light from Cy5.5 lies between 670 and 720 nm. This is comparable to the range of 0.45 to 0.68 mm -1 reported by Zijp et al. for pig muscle with wavelengths greater than 630 nm [3] .
It is notable that although the rate of decay of the Cy5.5 radiation in tissue is much higher than that of the gamma emission of 99m Tc, the relative rates of decay of the two types of radiation in time are just the opposite. In our tests, the optical signal showed no measurable reduction in fluorescent intensity after one week, whereas the 6 hour half-life of 99m Tc resulted in a reduction in its emission intensity by a factor of 2 28 (2.7 x 10 8 ) in that time.
Stereotactic Gamma Localization
The goal of this experiment was to test the feasibility of using gamma ray-based source localization to make attenuation corrections to the measured optical signal. The mixing protocol for Cy5.5 and 99m
Tc was kept the same as mentioned in the above section i.e 3.75 µg of Cy 5.5 and 0.8 mCi of 99m Tc. The mixture was injected in a 4 mm inner diameter lesion and embedded in a phantom made of cooked ham at various depths. For each source depth, a fluorescence image was obtained using the IVIS Xenogen optical camera operated in the fluorescence mode. The light signal was characterized by measuring the average pixel value in a small region of interest (ROI) centered on the image of the lesion. using, Then, for each source depth, the phantom was imaged stereotactically using the gamma camera shown in Fig. 4 . Two gamma emission images were obtained, separated by 40 degrees. The difference in the imaged location of the lesion in the two views was used to calculate the lesion depth within the phantom. Using each calculated depth and the optical attenuation coefficient measured in A.1., the measured ROI pixel value in the corresponding optical image was corrected as follows:
where, corr P the corrected pixel value, raw P is the uncorrected pixel value, eff µ is the effective attenuation coefficient and t is the calculated ham thickness. The error in the measured pixel value (compared to that measured with zero attenuation) before and after correction is shown in Fig. 5 . Note that -100% error corresponds to zero light signal. 
B. CT/Bioluminescence Study
In situations where the optical emission originates from a specific anatomical site (for example from a tumor or from a specific organ), it may be possible to use CT to aid in attenuation correction of the measured optical signal. To test this, we performed a CT/bioluminescence phantom study. The bioluminescence source was created using the ATP-lite 1 step bioluminescent kit from Perkin Elmer. . The kit is primarily intended as an ATP monitoring assay based on luciferin, luciferase and ATP. A small quantity of the luciferace/luciferin/ATP mixture was first used to measure the attenuation of luciferace light by the surrogate biologictissue. The results are shown in Fig. 6 Although a simple single exponential model for the net attenuation is not as good an approximation as it was in the case of the fluorescence study above, a best fit line to the data of Fig. 6 yields an attenuation coefficient of 0.42 mm -1 . A phantom was prepared with 1 µM (80 ul) of the luciferace assay and combined with 40 µl of gadolinium xray contrast. 100 ul of the mixture was injected into a small breast lesion (4mm inner diameter) and embedded in a cylindrical ham phantom, ~2.4 cm diameter. The phantom was placed in an acrylic cylinder of 1" inner diameter and 0.7 mm wall thickness. The phantom was rotated in steps of 45 degrees over 360 degrees (8 views) and the transmitted light out was measured using the IVIS Xenogen camera. The same phantom was then scanned in the tri-modality scanner, which was equipped with a Hamamatsu model C7940DA-02 x-ray detector and a Source-ray x-ray source (model SB-40-1k, Source-ray Inc., Bohemia, NY). The scan was over 360 degrees, with 0.72 degree increments (500 views). A photo of the phantom inside the tri-modality gantry is shown in Fig. 7 . To attenuation correct the light output from the optical camera, an axial CT slice (Fig. 8) through the lesion was used to determine, for each view, the total thickness of the ham between the lesion and the phantom surface. Air gaps within the phantom were identified in the CT image, and were subtracted from the total distance from the lesion center to the surface of the phantom to arrive at the total ham thickness. Correction to the ROI pixel values in the optical images were performed according to equation (1) . Figure 9 shows the pixel values 
III CONCLUSIONS
Our preliminary tests suggest that it may be possible to use gamma emission or x-ray transmission information to improve estimates of light output from fluorescence or bioluminescence sources. The single exponential model used here is certainly only approximate, and provides only a rough attenuation correction. Accurate quantification of the optical signal will require careful modeling of the depth dependent hardening of the transmitted beam. However, even this overly simplified model results in significant improvement. Further tests are needed to validate this approach for in vivo imaging, where the optical attenuation paths are less homogeneous, and reflection from tissue boundaries within the animal could be significant.
